EXMCeuticals Inc. (C:EXM)

Business Focus: N/A

Get the company report for the most recent outlook updated daily

Nov 04, 2021 01:40 pm ET

CSE Bulletin: Suspensions (MMI, CNFA, VPN, NM, EXM)

Toronto, Ontario--(Newsfile Corp. - le 4 novembre/November 2021) Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.

Jun 30, 2021 10:52 pm ET

EXMceuticals Inc. Announces Resignation of Board Members

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), announced today that Mr. Morten Borch and Mr. Bobby Doyon have both resigned as members of the Board of Directors. Mr. Borch is reducing his general business and board...

May 11, 2021 09:00 am ET

EXMceuticals Inc is Pleased to Announce the Signing of the Definitive Business Combination Agreement with Global Cannabinoids and Launch of its up-to $6,000,000 CAD Private Placement

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is very pleased to announce: (i) the signing of the definitive business...

Mar 03, 2021 10:26 am ET

EXMceuticals Inc. Announces Transformational Merger with Global Cannabinoids and Launches Concurrent Equity Financing

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce: (i) a proposed merger (the “Merger”) with Global...

Mar 01, 2021 07:07 am ET

IIROC Trading Halt - EXM

VANCOUVER, BC, March 1, 2021 /CNW/ - The following issues have been halted by IIROC:

Feb 01, 2021 01:01 pm ET

IIROC Trade Resumption - EXM

VANCOUVER, BC, Feb. 1, 2021 /CNW/ - Trading resumes in:

Jan 08, 2021 07:08 am ET

IIROC Trading Halt - EXM

VANCOUVER, BC, Jan. 8, 2021 /CNW/ - The following issues have been halted by IIROC:

Dec 10, 2020 06:22 pm ET

EXMceuticals Provides Bi-Weekly Default Status Report

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). On October 23, 2020, the Company announced...

Nov 26, 2020 10:38 pm ET

EXMceuticals Provides Bi-Weekly Default Status Report

Nov 12, 2020 04:46 pm ET

EXMceuticals Provides Bi-Weekly Default Status Report

Oct 23, 2020 06:24 pm ET

EXMceuticals Announces Application for Voluntary Management Cease Trade Order

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) announces that it has applied for a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial...

Sep 29, 2020 09:00 am ET

EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (OTCQB:EXM…, (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce its membership to The Portuguese...

Sep 08, 2020 09:00 am ET

EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce its success in securing COVID-19 R&D-focused grant from...

Aug 25, 2020 08:00 am ET

EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-science company specializing in the production of unique cannabinoid formulations, is pleased to announce the advancement of its R&D operations at its Lisbon,...

Aug 21, 2020 09:16 pm ET

EXMceuticals Inc. Announces Shares for Debt Settlement

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”) announces that it has settled $1,378,241 of debt with creditors by issuing 4,139,161 common shares of the Company at deemed prices of $0.275, $0.30, $0.32, and $0.35 per share. The...

Jul 28, 2020 04:39 pm ET

EXMceuticals Inc. Announces Loan Settlement and Share Issuance

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”) is pleased to announce that further to its news release dated July 22, 2020, pursuant to certain loan agreements previously entered into between the Company and certain lenders,...

Jul 22, 2020 03:18 pm ET

EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is pleased to announce that it has completed the sale of 5,180,000 units on a private placement basis at a price of $0.20 per unit for total cash proceeds of $1,036,000 (the...

Jun 11, 2020 09:00 am ET

EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), is pleased to announce that it has entered into a letter of intent ("LOI") with Econnabis SAS, an operating subsidiary of Plena Global Holdings Inc. (“Plena Global”), a...

May 29, 2020 02:34 pm ET

EXMceuticals Inc. Receives 45-Day Extension to File Quarterly Financial Statements

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), has provided an update on the status of the filing of its quarterly financial statements for the Q3 filings ended March 31, 2020. On March 18, 2020, the Canadian Securities...

May 07, 2020 08:00 am ET

EXMceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging producer of refined cannabis ingredients serving the pharmaceutical, medical, nutraceutical, and cosmetic industries, has secured a supply agreement-in-principle of...

Mar 25, 2020 09:00 am ET

EXMceuticals Inc. provides an update on operations and announces first closing of loan agreement

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), a producer of refined cannabis ingredients for the pharmaceutical, medical, nutraceutical, and cosmetic industries, provides an update on our operations, the first closing of a...

Mar 03, 2020 09:17 am ET

EXMceuticals Inc. provides an update on activities and announces a new Board Member and Corporate Secretary

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to give a brief update on its...

Feb 06, 2020 01:00 pm ET

EXMceuticals Inc. appoints Michael Kinley as CFO

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce the appointment of...

Feb 03, 2020 08:00 am ET

EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor

Jan 20, 2020 08:00 am ET

EXMceuticals Inc. appoints Nick Davis as Board Advisor

Jan 14, 2020 09:00 am ET

EXMceuticals Inc. names Paulo Martins as Chief Executive Officer for Portugal operations

Dec 11, 2019 09:00 am ET

EXMceuticals Inc. Provides Corporate Update

Nov 26, 2019 05:02 pm ET

EXMceuticals Provides Bi-Weekly Default Status Report

Nov 21, 2019 12:48 pm ET

EXMceuticals Inc. announces appointment of new CEO

Nov 12, 2019 08:00 pm ET

EXMceuticals Provides Bi-Weekly Default Status Report

Oct 29, 2019 09:44 pm ET

EXMceuticals Granted Management Cease Trade Order

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company’s request for, and has granted, a management cease trade order (the...

Oct 23, 2019 07:11 pm ET

EXMceuticals inc. applies for a for a voluntary management cease trade order

Oct 23, 2019 09:00 am ET

EXMceuticals obtains its research and development license for its TecLab facilities in Portugal

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis is pleased to announce that it has obtained the licence for cannabis research and development from INFARMED, the Portuguese...

Sep 27, 2019 12:12 pm ET

Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite

Horizons ETFs maintains the world's largest suite of cannabis ETFs

Sep 10, 2019 09:00 am ET

EXMCeuticals Inc. provides Corporate Update

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries is very pleased to provide a...

Aug 20, 2019 09:00 am ET

EXMceuticals Inc. appoints cannabis industry leader Tripp Keber as Strategic Advisor to the Board

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is proud to announce it has...

Jul 31, 2019 09:00 am ET

Significant progress in EXMceuticals Portuguese Operations with R&D facility, New Project and Pilot-Scale Refinery

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), a cultivator and producer of high-grade cannabis extracted ingredients for the pharmaceutical, therapeutic, nutraceutical, and cosmetic industries, is pleased to provide an update on its Portuguese activities.

Jul 24, 2019 03:30 pm ET

EXMceuticals Inc. Issues Shares for Debt

All common shares issued pursuant to the debt settlement are subject to a four month hold period under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

Jul 09, 2019 10:16 am ET

EXMceuticals Inc Announces New Strategic Initiative

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries is very pleased to announce it has appointed as its Canadian adviser Haywood Securities. Haywood will provide financial advisory services and assist with the future development of the Company. Haywood will work closely with Merlin partners LLP, EXM's existing London-based adviser.

Jul 08, 2019 10:08 am ET

EXMceuticals Inc. Announces Resignation of Director and CFO

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2019) - EXMceuticals Inc. (CSE: EXM) (WKN: A2PAW2) (the "Company" or "EXM") announces that effective as of June 30, 2019 Mr. Christopher Gulka has resigned as the Company's Chief Financial Officer and member of the board of directors, for personal reasons. As mentioned by Mr. Gulka: "It was a difficult decision to take, as it is very interesting to be a witness of the company's rapid expansion, but I trust I leave it in competent hands and good order."

Jun 11, 2019 04:00 am ET

EXMCeuticals Inc. Update on Proposed Acquisition in the Republic of Malawi

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: EXM), a cultivator and producer of medical grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to provide an update on the proposed acquisition of MM (Operations) Ltd. ("MM Ltd"), as announced on 7 May 2019, an established agro-processing business in the Republic of Malawi.

Jun 10, 2019 09:23 am ET

IIROC Trade Resumption - EXM

VANCOUVER, June 10, 2019 /CNW/ - Trading resumes in:

Jun 10, 2019 09:00 am ET

EXMceuticals Inc. Obtains Its Formal Licence in Uganda

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: EXM), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce that it has received its formal full authorisations and permits for its Uganda operations. This allows for the large-scale cultivation of cannabis, the extraction of cannabis ingredients and the export of the extracts.

Jun 10, 2019 08:50 am ET

IIROC Trading Halt - EXM

VANCOUVER, June 10, 2019 /CNW/ - The following issues have been halted by IIROC:

Jun 03, 2019 09:13 am ET

EXMceuticals Announces Appointment of New Chairman

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: EXM) (the "Company" or "EXM") the emerging low-cost operator in the high growth CBD and cannabis extracted ingredients market announces the appointment of its new London-based chairman and member of the board of directors, Mr. Jonathan Summers. Jonathan takes over the role from the previous incumbent Mr. John Anderson. The succession is effective immediately.

May 07, 2019 09:30 am ET

EXMceuticals Inc. to Expand Production Capacity by Acquisition in the Republic of Malawi

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2019) - EXMceuticals Inc. (CSE: EXM) (FSE: EXM) ("EXM") is pleased to announce that it has entered into a non-binding heads of terms to acquire MM (Operations) Ltd. ("MM Ltd"), an agro-processing business in the Republic of Malawi.

Feb 05, 2019 09:10 am ET

CSE New Listing - EXMceuticals Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - February 5, 2019) - EXMceuticals Inc. (CSE: EXM) is one of the latest new listing on the Canadian Securities Exchange, having previously traded as Orofino Minerals. The company specializes in the sustainable cultivation, processing and export of organic, pharmaceutical-grade cannabinoid ingredients from Africa.

Ad blocking detected

EXMCeuticals Inc. (C:EXM)

Business Focus: N/A